Search results for: 'Smart Hospital Market'
- Related search terms
- Smartphone-based Point-of-care Testing Innovations and Growth Opportunities
- market analysis of rf energy harvesting technolog
- market analysi of rf energy harvesting technolog
- market+size+of+china's+overseas+marketing+industry
- market 08 00 00 00
-
28 Mar 2019  |  Asia Pacific  |  Market Research
Malaysian Clinical Laboratories Market, Forecast to 2025
Shift toward Preventive Healthcare is Driving Market Growth
The market for healthcare services in Malaysia is less developed, with many clinical testing services being unavailable outside of cities. Unsubstantiated disease and unconfirmed mortality diagnoses are common in the country despite universal care, significant mixed investment in the local healthcare system, and health expenditure favourable to oth...
$1,500.00
Special Price $1,125.00 save 25 %
-
28 Mar 2019  |  Asia Pacific  |  Market Research
Thailand Clinical Laboratories Market, Forecast to 2025
Rising Demand for Diagnostics Services from the Ageing Population and Growing Prevalence of Chronic Diseases to Drive Market Growth
This study focuses on clinical lab services in Thailand. A detailed analysis is provided on clinical testing services at public hospital labs and private hospital labs. Specialised labs are integrated into the independent reference labs segment. Certain trends with regard to physician office labs (POLs) in retail clinics have been mentioned in the ...
$1,500.00
Special Price $1,125.00 save 25 %
-
04 Apr 2019  |  Asia Pacific  |  Market Research
Chinese Clinical Laboratories Market, Forecast to 2025
Investment in Private and Specialty Care Clinics Drives Growth
China is one of the fastest growing healthcare markets in the world. Traditionally, healthcare services have been dominated by the public sector; however, 2014 onward, the trend reversed with greater private sector participation. China still faces a number of challenges: unequal distribution of healthcare resources across the country; lack of an ef...
$1,500.00
Special Price $1,125.00 save 25 %
-
01 Apr 2019  |  Asia Pacific  |  Market Research
Vietnamese Clinical Laboratories Market, Forecast to 2025
Increase in Universal Health Support for Private Healthcare will Boost Test Volumes in Both Public and Private Sectors
Clinical laboratories are an essential part of the health industry. Approximately 80% of physicians' diagnoses is estimated to be the result of laboratory tests. The constant pressure to reduce healthcare spending is shifting healthcare application in favor of the laboratory, making it a more valuable part of the treatment plan. Vietnam CLT marke...
$1,500.00
Special Price $1,125.00 save 25 %
-
07 Jun 2019  |  Asia Pacific  |  Market Research
Growth Insights in APAC Infectious Disease Point-of-Care Testing (POCT) Market, Forecast to 2023
The Rising Prevalence of TB, HIV, and Hepatitis, Accompanied by the Development of Portable POCT Devices will Propel the APAC Infectious Diseases POCT Market
This study presents an overview of the Asia-Pacific infectious disease point-of-care testing (POCT) market with an emphasis on some of the key trends and growth opportunities that are shaping the market. The study highlights some of the emerging business models supporting the development and adoption of innovative diagnostic tests. The Asia-Pacif...
$3,000.00
Special Price $2,250.00 save 25 %
-
20 Mar 2019  |  North America  |  Market Research
Growth Opportunities in the North American Clinical Laboratory Services Market, Forecast to 2022
Laboratories Seek Alternate Revenue Streams to Combat Reimbursement Pressure
Clinical laboratory services represent one of the highest healthcare expenditures in North America, yet the United States and Canada represent different scenarios in the way clinical services are rendered. The market for clinical lab services in Canada was an estimated $10.33 billion in 2017 whereas in the United States it was an estimated $78.33 b...
$4,950.00
Special Price $3,712.50 save 25 %
-
11 Mar 2019  |  North America  |  Market Research
Global Cell Therapy Market—Companies to Action, 2018
A Collaborative Business Model With Focus on Stem Cells, Chimeric Antigen Receptor T (CAR-T) Cells and Combination Therapies Will Propel Market Growth
The global pharmaceutical industry is continuously evolving. with the rising need for novel therapies in the ever-changing disease landscape. As a result of rising prevalence of chronic infectious diseases as well as continuously growing number of cancer cases, market needs are shifting from traditional, small molecules to novel, large-molecule the...
$3,000.00
Special Price $2,250.00 save 25 %
-
10 Apr 2019  |  Africa  |  Market Research
Generic Pharmaceutical Market in Kenya and Nigeria, Forecast to 2022
Greater Regulatory Control and a Shift of Focus Away from Costly and Branded Drugs will Increase Generic Drugs’ Market Share
The African continent grapples with a huge burden of communicable diseases, particularly HIV/AIDS, tuberculosis, and malaria. With African governments facing major health financing challenges, a significant proportion of these disease areas are financed by global aid organizations that are also helping in poverty eradication in the continent. Paral...
$3,000.00
Special Price $2,250.00 save 25 %
-
06 Nov 2019  |  North America  |  Market Research
Growth Opportunities in Human Microbiome Market, Forecast to 2023
Strategic Collaborations and Stakeholder Awareness Along with Clear Paths to Commercialization will Play a Key Role for Success in the Human Microbiome Market
Interest in the microbiome as a science and industry has exploded over the past decade. Innovations are happening across 3 significant categories for human health benefits: microbiome-based therapeutics, over-the-counter (OTC) dietary supplements, and self-diagnostics/screening. The OTC market is the largest because of the lack of precise regulatio...
$4,950.00
Special Price $3,712.50 save 25 %
-
23 Sep 2019  |  North America  |  Frost Radar
Frost Radar in the Immunoassay and Clinical Chemistry Market
A Measurement System to Spark Companies 2 Action (C2A)—Innovation That Fuels New Deal Flow and Growth Pipelines
The immunoassay and clinical chemistry market is the highest share contributor for the total in vitro diagnostics (IVD) market. Globally valued at $28.7 billion in 2019, this market segment contributes 37.6% of the total IVD market of $76.3 billion. Within the high-medium to low analyzer segment, there are over 40 companies globally. Of these, 14 c...
$4,950.00
Special Price $3,712.50 save 25 %